{
  "type": "hyp",
  "text": "IkappaBalpha was degraded normally following stimulation in both normal controls and T cells from RCC patients. RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\n",
  "self": {
    "NER": {
      "answers": [
        "IkappaBalpha",
        "RCC",
        "RelA",
        "RelA/NF-kappaB1"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What protein was degraded after stimulation?",
          "What type of patient had a higher cytoplasmic level of RelA and",
          "What binding complexes did RCC-S suppress?",
          "What binding complexes did RCC-S inhibit?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "IkappaBalpha",
        "stimulation",
        "both normal controls",
        "T cells",
        "RCC patients",
        "RCC-S",
        "the cytoplasmic levels",
        "RelA",
        "NF-kappaB1",
        "their nuclear localization",
        "the activation",
        "RelA/NF-kappaB1 binding complexes"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What protein was degraded after stimulation?",
          "What did RCC-S do to IkappaBalpha?",
          "In what patients was IkappaBalpha degraded?",
          "What type of cells were stimulated with RCC-S?",
          "What type of T cells were stimulated with RCC-S?",
          "What treatment did not alter the cytoplasmic levels of RelA and NF-",
          "What did RCC-S not alter?",
          "What binding complexes did RCC-S suppress?",
          "What binding complexes did RCC-S suppress?",
          "What did RCC-S suppress?",
          "What did RCC-S inhibit?",
          "What did RCC-S inhibit?"
        ]
      }
    }
  },
  "asked": {
    "What protein was degraded after stimulation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "IkappaBalpha",
        "answerability": 0.9831377863883972,
        "ground_truth": {
          "IkappaBalpha": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What type of patient had a higher cytoplasmic level of RelA and": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1788964867591858,
        "ground_truth": {
          "RCC": {
            "bertscore": 0.6816697120666504,
            "f1": 0
          }
        }
      }
    },
    "What binding complexes did RCC-S suppress?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "RelA/NF-kappaB1",
        "answerability": 0.9664667248725891,
        "ground_truth": {
          "RelA": {
            "bertscore": 0.742443859577179,
            "f1": 0
          },
          "NF-kappaB1": {
            "bertscore": 0.9146257042884827,
            "f1": 0
          }
        }
      }
    },
    "What binding complexes did RCC-S inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "RelA/NF-kappaB1",
        "answerability": 0.9871008396148682,
        "ground_truth": {
          "RelA/NF-kappaB1": {
            "bertscore": 0.9999997615814209,
            "f1": 1.0
          }
        }
      }
    },
    "What did RCC-S do to IkappaBalpha?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "suppress their nuclear localization",
        "answerability": 0.9893589615821838,
        "ground_truth": {
          "stimulation": {
            "bertscore": 0.7099173665046692,
            "f1": 0
          }
        }
      }
    },
    "In what patients was IkappaBalpha degraded?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "normal controls and T cells from RCC patients",
        "answerability": 0.9112502336502075,
        "ground_truth": {
          "both normal controls": {
            "bertscore": 0.7677927017211914,
            "f1": 0.36363636363636365
          }
        }
      }
    },
    "What type of cells were stimulated with RCC-S?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "T cells",
        "answerability": 0.7393954992294312,
        "ground_truth": {
          "T cells": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What type of T cells were stimulated with RCC-S?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3354714512825012,
        "ground_truth": {
          "RCC patients": {
            "bertscore": 0.6449688673019409,
            "f1": 0
          }
        }
      }
    },
    "What treatment did not alter the cytoplasmic levels of RelA and NF-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "RCC-S",
        "answerability": 0.7001954317092896,
        "ground_truth": {
          "RCC-S": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What did RCC-S not alter?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "cytoplasmic levels of RelA and NF-kappaB1",
        "answerability": 0.9810687899589539,
        "ground_truth": {
          "the cytoplasmic levels": {
            "bertscore": 0.8051773309707642,
            "f1": 0.5
          }
        }
      }
    },
    "What did RCC-S suppress?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "nuclear localization",
        "answerability": 0.9882678389549255,
        "ground_truth": {
          "their nuclear localization": {
            "bertscore": 0.8988522887229919,
            "f1": 0.8
          }
        }
      }
    },
    "What did RCC-S inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "the activation of RelA/NF-kappaB1 binding complexes",
        "answerability": 0.8084094524383545,
        "ground_truth": {
          "the activation": {
            "bertscore": 0.6827995777130127,
            "f1": 0.33333333333333337
          },
          "RelA/NF-kappaB1 binding complexes": {
            "bertscore": 0.935600757598877,
            "f1": 0.7499999999999999
          }
        }
      }
    }
  }
}